The Problem
Our Solution
Our Solution
Medicine today operates with a massive blind spot: 94% of all genomic data excludes African and Indigenous ancestry, leading to biased drugs, poor efficacy, and treatments that miss the needs of most of the world.
Because critical variants in underrepresented genomes remain unstudied, 60% of rare diseases are still unsolved, delaying breakthroughs and blocking new therapeutic pathways.
This incomplete data foundation forces R&D teams to operate in the dark, resulting in over $200B wasted every year on Euro-centric research that delivers lower ROI and stalled discovery.
The next trillion-dollar breakthrough isn’t missing — it’s simply hidden in the 6% of humanity medicine has overlooked.
Our Solution
Our Solution
Our Solution
IndyGeneUS Bio solves the representation gap with our Clinico-Genomic Insight Engine™ — a proprietary platform that transforms ethically sourced genomic and clinical data into actionable, monetizable insights.
We combine world-class processing for genomics, proteomics, and multi-omics with sovereign-ready cloud infrastructure to generate the highest-quality datasets from underrepresented populations.
Every data point is ethically sourced, blockchain-secured, and governed with transparent community participation. Powered by Oracle’s sovereign cloud, our engine delivers decision-grade insights for drug discovery, therapeutic development, and precision health.
The result: diverse data that is trusted, secure, and capable of unlocking the scientific breakthroughs the world has been missing.
Mission & Vision
Why Gene Diversity Is Critical?
Why Gene Diversity Is Critical?
To pioneer the world’s first
BioFinTech platform transforming underrepresented genomic data into equity, discovery, and health sovereignty.
We fuse AI, blockchain, and genomics to create a new asset class: Biological Capital, where data contributors become stakeholders in the trillion-dollar precision-health economy.
Why Gene Diversity Is Critical?
Why Gene Diversity Is Critical?
Why Gene Diversity Is Critical?
40–50% more genetic variation in African and Indigenous genomes (Nature 2022; Cell Genomics 2023).
This reveals 4.6 million unique variants linked to immunity, cancer, and cardiometabolic disease.
Inclusive data is regulatory, scientific, and economic alpha — turning the world’s greatest untapped dataset into equitable global health value.
The Assets We Steward
Why Gene Diversity Is Critical?
The Assets We Steward
IndyGeneUS Bio has the two largest African genomic repositories, totaling 700K+ analyzable whole-blood samples.
South Africa – The Aurum Institute and Global Health Innovations:
- 500K+ samples: Strong representation in HIV, TB, and cardiometabolic diseases
Nigerian Biobank:
- 206K+ samples: Deep data in cancer, infectious disease, and rare disorders
How We're Different
Quantum + AI
Digital Twin Technology
Differentiated Data
Advanced analytics to accelerate therapeutic discovery.
Differentiated Data
Digital Twin Technology
Differentiated Data
The world’s most comprehensive African diaspora genomic biobank.
Digital Twin Technology
Digital Twin Technology
Digital Twin Technology
Secure, precise modeling of health and disease at scale.
BioFinTech Model
Digital Twin Technology
Digital Twin Technology
Transforming genomic insights into sustainable wealth creation.